EXECUTIVE DIRECTORS

Ms. Zhao Yan, aged 44, is the Chairman and an executive Director. Ms. Zhao had been a director of Freda Biopharm since 2003. She is a director of all the subsidiaries of the Company. Ms. Zhao graduated with a bachelor degree in science with major in biology from the East China Normal University（華東師範大學）in 1986 and completed an international MBA program organized by the China Center for Economic Research at Peking University from 2000 to 2002, and was awarded a master degree of business administration by Fordham University of the US in 2002. From 2000 to 2002, she was the general manager of Bloomage Holystar Investment Co., Ltd.（華熙昕宇投資有限公司）, a company engaged in the provision of venture capital, investment management and consultancy services and business management consultancy services. Presently, Ms. Zhao is also the chairman and general manager of Bloomage International Investments Group Inc. (formerly known as Bloomage Investments Co., Ltd) (“Bloomage International”), an investment holding company the subsidiaries of which are principally engaged in property development and investments in the PRC as well as operation and management of stadium and commercial projects in the PRC. Ms. Zhao is primarily responsible for the Group’s corporate policy formulation, business strategic planning and business development. Ms. Zhao is the director of AIM First Investments Limited (“AFI”) and Forever Shining Holdings Limited (“Forever Shining”) which hold 58.5% and 3.75% interest in the Company respectively.

Mr. Guo Jiajun (Song), aged 35, is an executive Director and the Chief Executive Officer. He graduated from Shandong University at Weihai（山東大學威海分校）in 1998 with a bachelor degree of science with major in electronics and information systems and completed an international MBA program organized by the China Center for Economic Research at Peking University from 2005 to 2008, and was awarded a master degree of business administration by Fordham University of the US in 2008. He worked for the Housing Fund Management Centre of Weihai Finance Bureau in Shandong（山東省威海市住房公積金管理中心）as a staff member and was responsible for the management and payment of housing funds from 1998 to 2001. He was the manager of the administration department of Bloomage International, an investment holding company (the subsidiaries of which are principally engaged in property development and investments in the PRC as well as operation and management of stadium and commercial projects in the PRC). He is primarily responsible for the Group’s strategic development and investment planning. He is also responsible for supervising the management team of the Group to implement and execute decisions of the Board. He is a director of Freda Biopharm. He joined the Group in March 2006.

Ms. Wang Aihua, aged 33, is an executive Director. Ms. Wang joined the Group as a director of Shandong Freda Biopharmaceutical Co., Ltd., a subsidiary of the Company, in December 2008. She had also been the secretary to the Chairman and the Manager of the Overseas Business Department of Bloomage International Investments Group Inc. (formerly known as Bloomage Investments Co., Ltd.), a company controlled by Ms. Zhao Yan who is an executive director, the Chairman of the Board and one of the controlling shareholders of the Company, since July 2007 up to September 2011. Prior to that, she was an analyst of Golden Credit Rating International Co., Ltd. from May 2004 to June 2007. Ms. Wang graduated from Yanshan University (燕山大學) (formerly know as The Northeast Heavy Machinery Institute (東北重型機械學院)) in the PRC, majoring in International Economic and Trading in July 1999. In May 2004, she graduated as a postgraduate student at the same university majoring in the Management Science and Engineering.

INDEPENDENT NON-EXECUTIVE DIRECTORS

Ms. Zhan Lili, aged 38, was appointed as an independent non-executive Director on 1 September 2008. She completed her studies in business administration at the Faculty of Business Administration of Capital University of Economics and Business in 2003. Ms. Zhan was an assistant to the General Manager of Tomson (Shanghai) Company Limited（湯臣高爾夫（上海）有限公司）from 2000 to 2001, worked in the human resource department of the Beijing branch of Industrial Bank Co., Ltd.（興業銀行）from 2003 to 2007 and has been a president assistant of Beijing Hai Dian Science & Technology Development Co., Ltd.（北京海澱科技發展有 限公司）, a company engaged in investments in bio-technology and pharmaceuticals, electronics and information technology, environmental protection materials and property development, since 2007.

Mr. Zhang Fuping, aged 54, was appointed as an independent non-executive Director on 1 September 2008. He obtained an executive master of business administration degree from Tsinghua University（清華大 學）in 2006. Mr. Zhang is accredited as a senior economist in China. He has been a vice chairman, a vice secretary of the Party Committee（黨委副書記）and the general manager of Beijing Sanyuan Group Limited Company（北京三元集團有限責任公司）, the company together with its subsidiaries which are engaged in agriculture, livestock farming and food processing industry, from 2002 to April 2007. Since April 2007, Mr. Zhang has been the secretary of the Party Committee（黨委書記）and the chairman of Beijing Capital Apribusiness Group（北京首都農業集團有限公司）(formerly Beijing Sanyuan Group Limited Company（北京 三元集團有限責任公司）) and since June 2007, he has also been the chairman of Beijing Sanyuan Foods Co., Ltd.（北京三元食品股份有限公司）, a company listed on the Shanghai Stock Exchange. Save for his current directorship in Beijing Sanyuan Foods Company Limited（北京三元食品股份有限公司）and the Company, Mr. Zhang has not been a director of any listed companies in the past three years.

Mr. Qin Bin, aged 43, was appointed as an independent non-executive Director on 1 September 2008. He obtained a master degree in economics from Nanjing University（南京大學）in 1995 and a doctoral degree in economics from Renmin University of China（中國人民大學）in 1998. He worked at the management of overseas branches division of the Bank of China（中國銀行）from 1998 to 2000 as an officer and was responsible for statistics and analysis of the overseas business of the Bank of China. He worked at China Orient Asset Management Corporation（中國東方資產管理公司）since 2000, and is now the deputy general manager of the research and development department of China Orient Asset Management Corporation（中國東方資產 管理公司）. During his employment with China Orient Asset Management Corporation, Mr. Qin has handled financial restructuring and debt-equity swap works for corporations, in which he has to use his expertise including accounting and corporate finance. Mr. Qin was a director of CNNC Hua Yuan Titanium Dioxide Co., Ltd（中核華原鈦白股份有限公司）(“CNNC”), a company subsequently listed on the Shenzhen Stock Exchange on 3 August 2007 which is principally engaged in the manufacture and sale of titanium dioxide, from February 2004 to May 2006. Save as disclosed above, he has not been a director of any listed companies in the past three years. During his directorship with CNNC, Mr. Qin has, as a member of the board of directors, participated in the exercise of the following powers, including formulation of annual budget, profit distribution proposal, merger and acquisition proposal, share repurchase proposal, issue of debentures or other securities of CNNC. With Mr. Qin’s financial management experience and expertise and his educational background, the Directors believe that Mr. Qin possesses adequate financial management expertise as required under Rule 3.10(2) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) (the “Listing Rules”).